Caspase 3 and 7 Orchestrate Cytoprotective Autophagy and DNA Stress Response in Human Breast Cancer Cells

Study Background and Research Question

Cellular adaptation to stress is pivotal for both healthy tissue function and the development of disease, particularly in malignancies such as breast cancer. While caspases are well recognized as central mediators of apoptosis, accumulating evidence points to their non-apoptotic roles in cell biology. Prior research in Drosophila suggested effector caspases may support cytoprotective autophagy, but whether this function is conserved in human cells remained untested. The reference study (Samarasekera et al., 2025) set out to answer whether caspase 3 (CASP3) and caspase 7 (CASP7) contribute to autophagy and DNA damage responses under non-lethal stress conditions in human breast cancer cells.

Key Innovation from the Reference Study

This study provides direct evidence that CASP3 and CASP7, traditionally associated with cell death, play a pro-survival role by promoting cytoprotective autophagy and enhancing the DNA damage response in stressed but viable breast cancer cells. Notably, the authors discovered a non-canonical processing pathway for CASP7 under mild stress, leading to fragment generation with distinct functional properties. These results broaden our understanding of caspase biology and highlight their involvement in adaptive stress pathways, with implications for cancer therapy and cellular resilience mechanisms.

Methods and Experimental Design Insights

The investigators employed a multifaceted approach involving genetic, molecular, and biochemical assays in human breast cancer cell lines. They used CRISPR/Cas9-mediated knockout to generate CASP3 and CASP7 double-null cells, enabling the study of caspase-specific roles. Cells were subjected to metabolic stress via starvation and proteasome inhibition, simulating non-lethal adverse conditions. Key autophagy and DNA damage markers—including LC3B, ATG7, and H2AX phosphorylation—were monitored using transcript analysis and immunoblotting. To elucidate mechanistic details, the team mapped CASP7 fragments formed during stress and tested their ability to rescue DNA damage signaling in knockout backgrounds.

Core Findings and Why They Matter

• Cytoprotective autophagy requires CASP3/7: The loss of both CASP3 and CASP7 resulted in impaired expression of key autophagy genes (LC3B, ATG7) and reduced autophagic flux during nutrient deprivation or proteasome inhibition, demonstrating that these caspases support the cytoprotective arm of autophagy rather than cell death under these conditions (Samarasekera et al., 2025).
• DNA damage response is caspase-dependent: Knockout of CASP3 and CASP7 led to diminished phosphorylation of H2AX, a key DNA damage marker, suggesting that caspase activity facilitates the cellular response to genotoxic stress.
• Non-canonical CASP7 processing: Under sublethal stress, CASP7 undergoes cleavage by calpain at sites flanking the PARP1 exosite, generating stable p29/p30 fragments. These fragments can rescue DNA damage signaling in the absence of full-length CASP3/7, indicating a functional role beyond apoptosis.
• PARP1 modulation links caspase activity to stress adaptation: PARP1 cleavage was altered in double-knockout cells, implicating this DNA repair enzyme as a downstream effector of caspase-mediated adaptation.
• Genetic vulnerabilities revealed: The combined loss of CASP3/7 was synthetically lethal with BRCA1 deficiency, highlighting potential therapeutic strategies exploiting these pathways in cancer treatment.

Collectively, these findings shift the paradigm of effector caspase function, positioning CASP3 and CASP7 as integral to autophagy regulation and DNA repair during non-lethal cellular stress.

Comparison with Existing Internal Articles

Several recent reviews and workflow articles have highlighted the centrality of Nicotinamide Adenine Dinucleotide (NAD+) in metabolic signaling and stress responses. For example, "NAD+ in Cellular Stress Adaptation: Mechanisms and Assay Precision" discusses how NAD+ levels influence both autophagy and DNA repair, mechanisms closely linked to the caspase-driven processes identified in the current study. Additionally, "NAD+ in Metabolic Stress: Mechanisms and Strategic Leverage" explores the role of NAD+ as an enzymatic cofactor in autophagy assays, providing protocol guidance that complements the reference paper's mechanistic discoveries. The convergence of caspase and NAD+ pathways, particularly in PARP1-dependent DNA repair and metabolic signaling, suggests that integrating both perspectives could enhance assay design and mechanistic interpretation in future stress adaptation research.

Limitations and Transferability

While the study robustly demonstrates caspase-dependent autophagy and DNA damage responses in human breast cancer cells, it is limited by its focus on a single cell lineage and specific stress paradigms (starvation, proteasome inhibition). The transferability of these findings to other cell types, cancer models, or in vivo contexts remains to be systematically established. Furthermore, the precise interplay between caspase-generated fragments, PARP1 activity, and broader metabolic networks requires further biochemical dissection. Nevertheless, the genetic interaction with BRCA1 loss hints at broader relevance in cancer biology and therapeutic targeting.

Protocol Parameters

• CRISPR/Cas9 knockout: Use dual-guide RNA targeting for CASP3 and CASP7; validate complete loss of protein expression via immunoblot before stress induction experiments.
• Autophagy induction: Employ serum and amino acid starvation for 6–24 hours or treat with proteasome inhibitors (e.g., MG132 at 5–10 μM) to elicit cytoprotective autophagy in breast cancer cells.
• DNA damage response monitoring: Quantify H2AX phosphorylation by immunoblot or immunofluorescence at 4–8 hours post-stress to capture early DNA repair signaling.
• Fragment rescue assays: Express CASP7-p29/p30 fragments using transient transfection in double-knockout cells to assess restoration of DNA damage response markers.
• NAD+ supplementation (literature-backed suggestion): For studies probing PARP1 or sirtuin activity, supplement with 0.5–2 mM NAD+ in serum-free media, as recommended in metabolic signaling and DNA repair assays (internal guidance).

Research Support Resources

For researchers aiming to replicate or extend these autophagy and DNA repair workflows, Nicotinamide Adenine Dinucleotide (NAD+) (SKU B1793) from APExBIO offers a highly soluble, high-purity standard suitable for metabolic and enzymatic assays. Its stability and compatibility with both water and DMSO facilitate integration into protocols examining NAD+ as an enzymatic cofactor, autophagy modulator, or DNA repair substrate. As illustrated in recent workflow articles, supplementing with NAD+ can enhance the precision of stress adaptation and DNA damage response studies in mammalian systems.